Gene Bukhman, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Rheumatic Heart Disease | 10 | 2023 | 167 | 3.380 |
Why?
|
Hospitals, District | 11 | 2024 | 113 | 3.050 |
Why?
|
Poverty | 21 | 2024 | 2695 | 2.300 |
Why?
|
Rural Population | 13 | 2024 | 2267 | 2.100 |
Why?
|
Diabetes Mellitus, Type 1 | 9 | 2024 | 3451 | 1.250 |
Why?
|
Africa South of the Sahara | 9 | 2023 | 743 | 1.230 |
Why?
|
Heart Failure | 15 | 2024 | 11835 | 1.180 |
Why?
|
Cost of Illness | 11 | 2023 | 1940 | 1.090 |
Why?
|
Malawi | 11 | 2024 | 301 | 1.050 |
Why?
|
Developing Countries | 13 | 2024 | 2880 | 0.960 |
Why?
|
Rwanda | 14 | 2023 | 662 | 0.920 |
Why?
|
Health Services Accessibility | 12 | 2024 | 5396 | 0.900 |
Why?
|
Delivery of Health Care, Integrated | 6 | 2024 | 936 | 0.810 |
Why?
|
Drugs, Essential | 1 | 2022 | 70 | 0.790 |
Why?
|
Rural Health Services | 4 | 2021 | 381 | 0.720 |
Why?
|
Nutrition Disorders | 1 | 2021 | 205 | 0.720 |
Why?
|
Cardiomyopathies | 4 | 2023 | 1945 | 0.710 |
Why?
|
Qualitative Research | 5 | 2024 | 2958 | 0.710 |
Why?
|
Delivery of Health Care | 11 | 2023 | 5324 | 0.700 |
Why?
|
Endemic Diseases | 4 | 2017 | 191 | 0.690 |
Why?
|
Africa | 5 | 2023 | 707 | 0.680 |
Why?
|
Investments | 1 | 2021 | 148 | 0.670 |
Why?
|
Socioeconomic Factors | 6 | 2022 | 7803 | 0.660 |
Why?
|
Quality-Adjusted Life Years | 7 | 2020 | 1724 | 0.660 |
Why?
|
Crohn Disease | 2 | 2022 | 2275 | 0.640 |
Why?
|
Morbidity | 7 | 2020 | 1765 | 0.620 |
Why?
|
Social Justice | 2 | 2021 | 478 | 0.610 |
Why?
|
Social Class | 2 | 2019 | 2005 | 0.610 |
Why?
|
Endomyocardial Fibrosis | 2 | 2008 | 41 | 0.590 |
Why?
|
Haiti | 5 | 2024 | 550 | 0.580 |
Why?
|
Nurse's Role | 1 | 2018 | 188 | 0.570 |
Why?
|
Rheumatic Fever | 3 | 2023 | 75 | 0.570 |
Why?
|
Chronic Disease | 5 | 2024 | 9283 | 0.560 |
Why?
|
Preventive Medicine | 2 | 2015 | 250 | 0.550 |
Why?
|
Nursing Staff, Hospital | 2 | 2018 | 344 | 0.530 |
Why?
|
Healthy People Programs | 1 | 2015 | 53 | 0.500 |
Why?
|
Diabetes Mellitus | 4 | 2022 | 5884 | 0.500 |
Why?
|
Echocardiography, Doppler | 1 | 2018 | 900 | 0.480 |
Why?
|
Anemia, Sickle Cell | 2 | 2024 | 1056 | 0.480 |
Why?
|
Social Support | 1 | 2024 | 2145 | 0.470 |
Why?
|
Diabetes Mellitus, Type 2 | 7 | 2023 | 12281 | 0.470 |
Why?
|
Health Surveys | 4 | 2019 | 4061 | 0.460 |
Why?
|
Bronchodilator Agents | 1 | 2017 | 506 | 0.450 |
Why?
|
Hypertension | 6 | 2024 | 8595 | 0.450 |
Why?
|
Demography | 1 | 2019 | 1650 | 0.450 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15740 | 0.450 |
Why?
|
Trust | 2 | 2024 | 528 | 0.440 |
Why?
|
Humans | 93 | 2024 | 760261 | 0.430 |
Why?
|
Anti-Asthmatic Agents | 1 | 2017 | 565 | 0.410 |
Why?
|
Sterilization | 1 | 2012 | 130 | 0.390 |
Why?
|
Life Expectancy | 1 | 2019 | 1249 | 0.390 |
Why?
|
Disabled Persons | 3 | 2015 | 1226 | 0.390 |
Why?
|
Wounds and Injuries | 4 | 2021 | 2477 | 0.370 |
Why?
|
Colitis, Ulcerative | 1 | 2022 | 1919 | 0.350 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2297 | 0.350 |
Why?
|
Arrhythmias, Cardiac | 1 | 2020 | 2255 | 0.350 |
Why?
|
Ethiopia | 3 | 2022 | 463 | 0.340 |
Why?
|
Health Policy | 3 | 2020 | 2678 | 0.330 |
Why?
|
Forecasting | 1 | 2018 | 2931 | 0.330 |
Why?
|
Tuberculosis | 2 | 2014 | 2003 | 0.310 |
Why?
|
Cause of Death | 1 | 2019 | 3723 | 0.300 |
Why?
|
Health Priorities | 3 | 2023 | 376 | 0.300 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2022 | 2421 | 0.290 |
Why?
|
Serotonin 5-HT2 Receptor Agonists | 1 | 2007 | 31 | 0.290 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4317 | 0.280 |
Why?
|
Hospitals, Rural | 3 | 2024 | 175 | 0.280 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2015 | 2197 | 0.280 |
Why?
|
Health Care Costs | 1 | 2020 | 3257 | 0.270 |
Why?
|
Blood Glucose Self-Monitoring | 4 | 2023 | 457 | 0.260 |
Why?
|
Outpatient Clinics, Hospital | 2 | 2020 | 389 | 0.260 |
Why?
|
Stroke | 6 | 2023 | 9945 | 0.250 |
Why?
|
Liberia | 2 | 2022 | 174 | 0.240 |
Why?
|
Anemia | 1 | 2014 | 1511 | 0.240 |
Why?
|
Dopamine Agonists | 1 | 2007 | 352 | 0.240 |
Why?
|
Secondary Prevention | 3 | 2023 | 1548 | 0.230 |
Why?
|
Cardiac Surgical Procedures | 2 | 2018 | 3618 | 0.220 |
Why?
|
Primary Prevention | 3 | 2023 | 1207 | 0.220 |
Why?
|
Nepal | 2 | 2022 | 301 | 0.210 |
Why?
|
Defibrillators, Implantable | 1 | 2012 | 1499 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3206 | 0.210 |
Why?
|
Catastrophic Illness | 2 | 2022 | 59 | 0.210 |
Why?
|
Eosinophilia | 1 | 2007 | 560 | 0.200 |
Why?
|
Male | 30 | 2024 | 359413 | 0.200 |
Why?
|
Female | 33 | 2024 | 391011 | 0.200 |
Why?
|
Kenya | 3 | 2021 | 749 | 0.200 |
Why?
|
Income | 2 | 2020 | 1876 | 0.190 |
Why?
|
Tunisia | 1 | 2020 | 36 | 0.190 |
Why?
|
Prevalence | 11 | 2023 | 15687 | 0.190 |
Why?
|
Egypt | 1 | 2020 | 98 | 0.180 |
Why?
|
International Cooperation | 3 | 2017 | 1436 | 0.180 |
Why?
|
Asia, Southeastern | 1 | 2020 | 113 | 0.180 |
Why?
|
Ambulatory Care | 3 | 2024 | 2783 | 0.180 |
Why?
|
Senegal | 1 | 2020 | 256 | 0.170 |
Why?
|
Tanzania | 2 | 2024 | 1379 | 0.170 |
Why?
|
Insulin | 5 | 2023 | 6592 | 0.170 |
Why?
|
Adult | 20 | 2024 | 219847 | 0.170 |
Why?
|
Spirituality | 1 | 2024 | 428 | 0.170 |
Why?
|
Patient Acceptance of Health Care | 2 | 2024 | 3159 | 0.160 |
Why?
|
Heart Valve Diseases | 1 | 2007 | 1047 | 0.160 |
Why?
|
Hospitals, Public | 1 | 2020 | 201 | 0.160 |
Why?
|
Mozambique | 1 | 2019 | 55 | 0.160 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25928 | 0.160 |
Why?
|
Asthma | 1 | 2017 | 6167 | 0.160 |
Why?
|
Bangladesh | 1 | 2020 | 734 | 0.160 |
Why?
|
Review Literature as Topic | 1 | 2020 | 350 | 0.150 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 3 | 2023 | 323 | 0.150 |
Why?
|
India | 2 | 2024 | 2346 | 0.150 |
Why?
|
Acute Coronary Syndrome | 1 | 2011 | 2362 | 0.150 |
Why?
|
Middle Aged | 16 | 2024 | 220175 | 0.150 |
Why?
|
Mortality | 3 | 2020 | 2916 | 0.150 |
Why?
|
World Health Organization | 1 | 2023 | 1319 | 0.150 |
Why?
|
Capacity Building | 2 | 2017 | 258 | 0.140 |
Why?
|
Developed Countries | 1 | 2020 | 443 | 0.140 |
Why?
|
Ambulatory Care Facilities | 1 | 2023 | 926 | 0.140 |
Why?
|
Retrospective Studies | 12 | 2024 | 80301 | 0.140 |
Why?
|
Adolescent | 9 | 2020 | 87747 | 0.130 |
Why?
|
Long-Term Care | 1 | 2020 | 628 | 0.130 |
Why?
|
Referral and Consultation | 2 | 2020 | 3598 | 0.130 |
Why?
|
Nigeria | 1 | 2019 | 762 | 0.130 |
Why?
|
Health Expenditures | 4 | 2022 | 2359 | 0.130 |
Why?
|
HIV Infections | 4 | 2020 | 17159 | 0.130 |
Why?
|
Atrial Fibrillation | 1 | 2014 | 5201 | 0.120 |
Why?
|
Cardiology Service, Hospital | 1 | 2017 | 242 | 0.120 |
Why?
|
Risk Factors | 7 | 2023 | 74269 | 0.120 |
Why?
|
Education, Nursing, Diploma Programs | 1 | 2014 | 11 | 0.120 |
Why?
|
Remission Induction | 1 | 2020 | 2394 | 0.120 |
Why?
|
Primary Health Care | 2 | 2022 | 4649 | 0.120 |
Why?
|
Public Health | 1 | 2007 | 2655 | 0.120 |
Why?
|
Young Adult | 8 | 2020 | 58673 | 0.120 |
Why?
|
Health Status Disparities | 2 | 2016 | 1819 | 0.120 |
Why?
|
Communicable Diseases | 1 | 2022 | 879 | 0.110 |
Why?
|
Australia | 1 | 2017 | 1288 | 0.110 |
Why?
|
Public-Private Sector Partnerships | 1 | 2014 | 122 | 0.110 |
Why?
|
Women's Health | 1 | 2023 | 2057 | 0.110 |
Why?
|
Hot Temperature | 1 | 2019 | 1435 | 0.110 |
Why?
|
Incidence | 7 | 2023 | 21378 | 0.110 |
Why?
|
Medication Adherence | 1 | 2024 | 2163 | 0.100 |
Why?
|
Program Evaluation | 2 | 2018 | 2494 | 0.100 |
Why?
|
Liver Cirrhosis | 1 | 2023 | 1925 | 0.100 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2024 | 3967 | 0.100 |
Why?
|
Personnel, Hospital | 1 | 2014 | 285 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3929 | 0.100 |
Why?
|
Parasitic Diseases | 1 | 2012 | 76 | 0.100 |
Why?
|
Inservice Training | 1 | 2014 | 376 | 0.100 |
Why?
|
Blood Glucose | 5 | 2024 | 6375 | 0.100 |
Why?
|
Neglected Diseases | 1 | 2012 | 66 | 0.100 |
Why?
|
Feasibility Studies | 4 | 2024 | 5201 | 0.100 |
Why?
|
Decision Trees | 1 | 2013 | 506 | 0.100 |
Why?
|
Urban Population | 1 | 2019 | 2021 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2020 | 1539 | 0.090 |
Why?
|
Cardiovascular Agents | 1 | 2017 | 864 | 0.090 |
Why?
|
Sex Distribution | 1 | 2015 | 2295 | 0.090 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 844 | 0.090 |
Why?
|
Needs Assessment | 1 | 2016 | 1137 | 0.080 |
Why?
|
Caregivers | 1 | 2021 | 2222 | 0.080 |
Why?
|
Health Resources | 1 | 2015 | 936 | 0.080 |
Why?
|
Models, Theoretical | 1 | 2021 | 3561 | 0.080 |
Why?
|
Medically Underserved Area | 1 | 2011 | 258 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 685 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2017 | 1192 | 0.080 |
Why?
|
Acute Disease | 1 | 2019 | 7268 | 0.080 |
Why?
|
Mental Health | 1 | 2023 | 3206 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2609 | 0.080 |
Why?
|
Peru | 1 | 2011 | 870 | 0.080 |
Why?
|
Echocardiography | 2 | 2013 | 4980 | 0.080 |
Why?
|
Medical Oncology | 1 | 2020 | 2321 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2021 | 5507 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2016 | 1399 | 0.070 |
Why?
|
Aged | 8 | 2024 | 168995 | 0.070 |
Why?
|
Follow-Up Studies | 3 | 2018 | 39254 | 0.070 |
Why?
|
Age Factors | 4 | 2020 | 18415 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2510 | 0.070 |
Why?
|
Occupational Diseases | 1 | 2015 | 1484 | 0.070 |
Why?
|
Delayed Diagnosis | 1 | 2011 | 463 | 0.070 |
Why?
|
Health Status | 1 | 2020 | 4081 | 0.070 |
Why?
|
Health Personnel | 2 | 2017 | 3310 | 0.070 |
Why?
|
Community Health Services | 1 | 2011 | 654 | 0.070 |
Why?
|
Models, Statistical | 1 | 2020 | 5073 | 0.060 |
Why?
|
Politics | 2 | 2024 | 815 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 15273 | 0.060 |
Why?
|
Medicare | 1 | 2023 | 6771 | 0.060 |
Why?
|
Tryptophan | 1 | 2007 | 480 | 0.060 |
Why?
|
Hypoglycemic Agents | 3 | 2023 | 3149 | 0.060 |
Why?
|
Interviews as Topic | 2 | 2024 | 2656 | 0.060 |
Why?
|
Epilepsy | 1 | 2020 | 3267 | 0.060 |
Why?
|
Infant | 4 | 2020 | 36030 | 0.060 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2020 | 3606 | 0.060 |
Why?
|
Disease Management | 1 | 2015 | 2508 | 0.060 |
Why?
|
Tertiary Prevention | 1 | 2023 | 8 | 0.060 |
Why?
|
Aged, 80 and over | 3 | 2020 | 58947 | 0.060 |
Why?
|
Child, Preschool | 4 | 2020 | 42034 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12806 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2021 | 4735 | 0.060 |
Why?
|
Sierra Leone | 1 | 2024 | 168 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2020 | 15827 | 0.050 |
Why?
|
Healthcare Disparities | 2 | 2015 | 3381 | 0.050 |
Why?
|
United States | 7 | 2023 | 72363 | 0.050 |
Why?
|
Research Design | 3 | 2024 | 6181 | 0.050 |
Why?
|
Maryland | 1 | 2022 | 275 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3607 | 0.050 |
Why?
|
Education, Medical, Graduate | 1 | 2014 | 2359 | 0.050 |
Why?
|
Insurance Benefits | 1 | 2023 | 191 | 0.050 |
Why?
|
Systems Analysis | 1 | 2022 | 169 | 0.050 |
Why?
|
Schizophrenia | 1 | 2020 | 6915 | 0.050 |
Why?
|
Biomedical Research | 1 | 2017 | 3421 | 0.050 |
Why?
|
History, 21st Century | 1 | 2007 | 1576 | 0.050 |
Why?
|
Atrial Flutter | 1 | 2023 | 258 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2015 | 4404 | 0.040 |
Why?
|
Angina, Unstable | 1 | 2005 | 926 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8621 | 0.040 |
Why?
|
Child | 5 | 2020 | 79758 | 0.040 |
Why?
|
History, 20th Century | 1 | 2007 | 2777 | 0.040 |
Why?
|
Cooperative Behavior | 2 | 2017 | 1500 | 0.040 |
Why?
|
Cohort Studies | 2 | 2023 | 41317 | 0.040 |
Why?
|
Costs and Cost Analysis | 1 | 2024 | 1679 | 0.040 |
Why?
|
Ischemic Attack, Transient | 1 | 2023 | 899 | 0.040 |
Why?
|
Family Characteristics | 1 | 2022 | 1001 | 0.040 |
Why?
|
South Africa | 1 | 2023 | 1821 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29636 | 0.040 |
Why?
|
Sex Factors | 1 | 2011 | 10530 | 0.040 |
Why?
|
Self Care | 1 | 2022 | 793 | 0.040 |
Why?
|
Furosemide | 1 | 2017 | 170 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2022 | 10340 | 0.030 |
Why?
|
Penicillin G Benzathine | 1 | 2016 | 25 | 0.030 |
Why?
|
Hospitalization | 1 | 2016 | 10761 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2021 | 968 | 0.030 |
Why?
|
Sanitation | 1 | 2015 | 86 | 0.030 |
Why?
|
Cardiac Imaging Techniques | 1 | 2017 | 269 | 0.030 |
Why?
|
Respiratory Tract Diseases | 1 | 2020 | 747 | 0.030 |
Why?
|
Government Agencies | 1 | 2014 | 161 | 0.030 |
Why?
|
Diuretics | 1 | 2017 | 612 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 64947 | 0.030 |
Why?
|
Organizations | 1 | 2014 | 171 | 0.030 |
Why?
|
Tropical Climate | 1 | 2012 | 35 | 0.030 |
Why?
|
Uganda | 1 | 2017 | 1326 | 0.030 |
Why?
|
Child Mortality | 1 | 2014 | 206 | 0.020 |
Why?
|
Quality of Life | 2 | 2024 | 13300 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1256 | 0.020 |
Why?
|
Inpatients | 1 | 2023 | 2578 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22066 | 0.020 |
Why?
|
Glucose | 1 | 2022 | 4361 | 0.020 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2017 | 1521 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2014 | 600 | 0.020 |
Why?
|
Internationality | 1 | 2015 | 1005 | 0.020 |
Why?
|
Patient Compliance | 1 | 2020 | 2689 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26168 | 0.020 |
Why?
|
Health Care Surveys | 1 | 2017 | 2434 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8553 | 0.020 |
Why?
|
Comorbidity | 1 | 2023 | 10552 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 54263 | 0.020 |
Why?
|
Program Development | 1 | 2014 | 1297 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2014 | 832 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1606 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2020 | 3870 | 0.020 |
Why?
|
Europe, Eastern | 1 | 2005 | 72 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2015 | 1809 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2014 | 2753 | 0.010 |
Why?
|
Health Behavior | 1 | 2015 | 2621 | 0.010 |
Why?
|
Electrocardiography | 1 | 2017 | 6413 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11891 | 0.010 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6661 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2020 | 4763 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6472 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5420 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3762 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2005 | 1723 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8449 | 0.010 |
Why?
|
Syndrome | 1 | 2005 | 3278 | 0.010 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 2005 | 1880 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7400 | 0.010 |
Why?
|
Animals | 1 | 2008 | 167940 | 0.010 |
Why?
|
Risk Assessment | 1 | 2015 | 24086 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12156 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2005 | 12532 | 0.010 |
Why?
|